Kennedy Jonathan 4
4 · NATUS MEDICAL INC · Filed Nov 6, 2019
Insider Transaction Report
Form 4
Kennedy Jonathan
Sr. VP, CFO
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value per share
2019-11-04$22.50/sh+5,000$112,500→ 144,517 total - Sale
Common Stock, $0.001 par value per share
2019-11-05$34.32/sh−4,268$146,478→ 140,841 total - Sale
Common Stock, $0.001 par value per share
2019-11-04$33.65/sh−4,408$148,329→ 140,109 total - Exercise/Conversion
Common Stock, $0.001 par value per share
2019-11-05$22.50/sh+5,000$112,500→ 145,109 total - Exercise/Conversion
Non-qualified Stock Option
2019-11-04−4,408→ 592 totalExercise: $22.50From: 2014-02-01Exp: 2020-01-01→ Common Stock (4,408 underlying) - Exercise/Conversion
Non-qualified Stock Option
2019-11-05−4,268→ 1,324 totalExercise: $22.50From: 2014-02-01Exp: 2020-01-01→ Common Stock (4,268 underlying)
Footnotes (2)
- [F1]1.This transaction was executed in multiple trades a prices ranging from $33.59 to $33.85. The price reflected above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]1.This transaction was executed in multiple trades a prices ranging from $34.30 to $34.33. The price reflected above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.